Home › NDC Lookup › RxCUI directory › RxCUI 2745127

Everolimus 10 MG Oral Tablet [Yulithira] — RxCUI 2745127

RxNorm drug concept · Semantic branded drug
RxCUI 2745127 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2745127
Official nameEverolimus 10 MG Oral Tablet [Yulithira]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asYulithira 10 MG Oral Tablet
FDA products mapped4
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Everolimus: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. Think of a pathway inside cells that acts like a gas pedal for growth — in cancer and tuberous sclerosis, that pedal gets stuck down and cells grow out of control....
  • What exactly is everolimus treating — how does it actually fight cancer or help with TSC?
  • Yes — but the key isn't which you choose, it's being consistent. Food — especially a high-fat meal — can significantly lower the peak blood concentration of everolimus. That's not...
  • Does it matter if I take everolimus with food or on an empty stomach?
📖 Read our full Everolimus guide →

🕸️ Concept Web — How Everolimus 10 MG Oral Tablet [Yulithira] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Everolimus 10 MG Oral Tablet [Yulithira] RxCUI 2745127

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Everolimus 141704
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Yulithira 2745122
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Everolimus Oral Tablet 845506
    • Everolimus Oral Product 1163786
    • Everolimus Pill 1163787
    • Everolimus Oral Tablet [Yulithira] 2745126
    • Yulithira Oral Product 2745124
    • Yulithira Pill 2745125
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Everolimus 10 MG Oral Tablet SCD · 845507
  • Everolimus 10 MG SCDC · 845505
  • Everolimus Oral Tablet SCDF · 845506
  • Everolimus Oral Product SCDG · 1163786
  • Everolimus Pill SCDG · 1163787

Brand-Name Concepts

  • Everolimus 10 MG [Yulithira] SBDC · 2745123
  • Everolimus Oral Tablet [Yulithira] SBDF · 2745126
  • Yulithira Oral Product SBDG · 2745124
  • Yulithira Pill SBDG · 2745125
  • Yulithira BN · 2745122

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 2745127 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
82249-0610-30 30 TABLET in 1 BOTTLE (82249-610-30) Yulithira CivicaScript, LLC 2026-06-11
82249-0611-30 30 TABLET in 1 BOTTLE (82249-611-30) Yulithira CivicaScript, LLC 2026-06-11
82249-0612-30 30 TABLET in 1 BOTTLE (82249-612-30) Yulithira CivicaScript, LLC 2026-06-11
82249-0613-30 30 TABLET in 1 BOTTLE (82249-613-30) Yulithira CivicaScript, LLC 2026-06-11
Observed labelers: CivicaScript, LLC (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.